N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. - Wikidata - awgldk - TriplyDB

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

http://www.wikidata.org/entity/Q31046921

about

BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study Determination of N-acetylaspartic acid concentration in the mouse brain using HPLC with fluorescence detection.Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system.Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals.Whole brain N-acetylaspartate concentration is conserved throughout normal aging.Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.The whole-brain N-acetylaspartate correlates with education in normal adults.Altered Local Spontaneous Brain Activity in Juvenile Myoclonic Epilepsy: A Preliminary Resting-State fMRI Study Global average gray and white matter N-acetylaspartate concentration in the human brain.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Body mass index and magnetic resonance markers of brain integrity in adults.Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.Obstructive sleep apnea is associated with altered midbrain chemical concentrations.Molecular biomarkers of epileptogenesis.Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.Determinants of the enzymatic activity and the subcellular localization of aspartate N-acetyltransferase.Proton magnetic resonance spectroscopy in patients with symptomatic unilateral internal carotid artery / middle cerebral artery stenosis or occlusion.Alzheimer-like brain metabolic and structural features in cholesterol-fed rabbit detected by magnetic resonance imaging.Neurometabolic and structural alterations in rat brain due to acute hypobaric hypoxia: in vivo 1H MRS at 7 T

P2860

Q33759530-2D2A58ED-8FC3-4E9F-8244-B209E05A7873 Q33891132-39774784-BD57-4972-8531-44F2B9C23E2F Q34148796-B699D306-DDE9-473E-A049-49A0403821A8 Q34706877-91D401F3-6E6E-478A-8F9A-D65EA740D6F1 Q35895046-FD2D4ED9-A8DE-44F9-B214-F8D29BED5B96 Q35925666-D7132960-DB09-4568-B81F-07066C970B2D Q35938583-D85247ED-0A28-49A5-BFE8-0AA165B3F35D Q36111496-F46B4E51-22DF-441B-8BF4-CE97BC1F350B Q36429303-341138B4-6946-4686-9EEB-E1ACC074B975 Q36448488-73A1CC52-3B3D-43EC-B611-9D915CDBBB0C Q36794040-5B5B1FC4-4C94-41F8-8556-E6EF6581AAB9 Q36856162-EFA9F2C1-2567-4565-8F18-6ECBD685C12F Q36889018-6487E037-3B1E-4E52-8931-5DA8DF20F187 Q37374156-8A9542E4-E920-498C-8210-FA0F06D9C398 Q43446462-56B97794-46E5-4F89-AA60-F3FBA4C24C8E Q48833684-C4E2050F-E69E-48DB-9AF9-EBDAD901D41D Q49074225-3EA79EF6-F4F6-4E20-BF25-D8A6CE942949 Q50511556-BBB2A2C7-A650-4735-92EA-837704493FA8 Q52613983-AF6390A4-868A-41B0-A807-CDA96FA37470 Q52627279-B058E412-AD15-4647-ACAA-5F5DA0C17032 Q57096764-3484CB5E-1D58-4B05-8B59-10518DDCB708

P2860

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

http://www.wikidata.org/entity/Q31046921

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@ast

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@en

type

label

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@ast

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@en

prefLabel

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@ast

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@en

P1433

Q31046921-5749D166-BB11-45B0-BB7D-3244697C302C

P1476

Q31046921-2B207D95-90A2-4678-8C84-2A318DE29EAF

P2093

Q31046921-03CA8D7B-4290-47A2-B663-4B62E0FC02D6

Q31046921-79E90E78-8A79-458B-9182-70D80F829E01

Q31046921-A299B0A4-2CDD-4233-9CE8-8A18D4FD1B90

Q31046921-AC5ED931-94FA-4F69-B7A1-53CCE59D8A93

Q31046921-E37174E1-1D5B-442A-BB25-61C1F61BED1B

P2860

Q31046921-03BF96D7-4571-4C75-BE0F-396F198B33C0

Q31046921-04659780-6F57-47C2-AED9-91E6C078BA73

Q31046921-0746C8B4-6E36-4EC1-9D3F-6EDFCE08EEF9

Q31046921-0C79A940-5BD9-4215-B846-29F194BA0E9D

Q31046921-0E66EFDD-8CA2-4801-A74E-717F54F3ABA8

Q31046921-15F51C30-D30D-495E-8225-F3BB84C150CD

Q31046921-2FC5B683-3681-4B09-84C4-5F87E874745F

Q31046921-39699FFC-C6BA-4261-BBFB-F7936B993E48

Q31046921-3A1F0233-0EDA-47BD-88EB-224BB64F334A

Q31046921-407BE4DD-595E-4BA7-B173-917CBA5DFE63

P304

Q31046921-2E4C25C1-42BF-4BBF-93D3-9704B9A2518B

P31

Q31046921-B4FE7BB9-DA62-4824-BAB0-9DD5FCD90FDC

P356

Q31046921-A3A7FA7F-B293-4E09-B4D2-EF8A66757461

P407

Q31046921-8E69BD39-1B89-4FCA-A833-395AE7C683CC

P478

Q31046921-EB7E877C-FD98-46EC-885B-7AF367FDC67D

P50

Q31046921-114D780B-EE02-4A34-A80B-1E4E4B16E2E8

Q31046921-FEE810C7-A0F2-4019-80AF-5FADD0906383

P577

Q31046921-06FA0F58-6F1B-4CB2-8861-195305E68A4A

P5875

Q31046921-2861D176-B217-4C8D-9716-E02D60EB7291

P698

Q31046921-E32C50FF-6E52-4239-A966-B428B6D39200

P921

Q31046921-02951E80-A4A9-47CB-9F01-15C0A18083C1

P932

Q31046921-C1E4619E-88EC-42CC-B770-694A2AEDBB0C

P356

0-387-30172-0_17

P1433

Advances in Experimental Medicine and Biology

P1476

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

@en

P2093

Diana Truran Sacrey

http://www.w3.org/2001/XMLSchema#string

Dieter J Meyerhoff

http://www.w3.org/2001/XMLSchema#string

Kenneth Laxer

http://www.w3.org/2001/XMLSchema#string

Norbert Schuff

http://www.w3.org/2001/XMLSchema#string

Susanne Mueller

http://www.w3.org/2001/XMLSchema#string

P2860

MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis.

Dementia due to subcortical ischemic vascular disease.

Biological markers in the diagnosis and treatment of ALS.

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.

Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis.

Neurotransmitter alterations in PTSD: catecholamines and serotonin.

Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder.

Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report.

MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder

Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.

P304

241-62; discussion 361-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/0-387-30172-0_17

http://www.w3.org/2001/XMLSchema#string

P407

P478

576

http://www.w3.org/2001/XMLSchema#string

P50

Michael W. Weiner

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6981410

http://www.w3.org/2001/XMLSchema#string

P698

16802717

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

1779762

http://www.w3.org/2001/XMLSchema#string